SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Instagram Outage Disrupts Thousands of U.S. Users 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Dutch healthcare technology giant Philips (EPA:TTEF) forecasted a 1% to 3% increase in comparable sales for 2025 despite ongoing challenges in China. The company missed market expectations for Q4 2024, reporting €5.04 billion ($5.27 billion) in revenue, slightly below analysts’ projections of €5.07 billion.
Philips attributed the weaker performance to a double-digit decline in China sales, which is expected to continue in 2025. The forecast includes a mid- to high-single-digit drop in Chinese revenue and the impact of new U.S.-China tariffs. CEO Roy Jakobs previously stated that China’s contribution to total revenue has fallen to around 10%, down from over 13% earlier in the decade. The company employs over 7,000 people in the country.
Despite the decline, Philips maintained its commitment to growth, with adjusted EBITA reaching €679 million for Q4, slightly below the €683 million analysts expected. The company proposed an annual dividend of €0.85 per share, consistent with the previous year.
Philips, known for its diverse portfolio from medical imaging systems to consumer electronics, had already lowered its 2024 sales forecast in October due to weak demand in China. The company’s ability to navigate global economic shifts, supply chain disruptions, and geopolitical challenges will be critical for its 2025 performance.
With a focus on stabilizing sales and overcoming market headwinds, Philips continues to adapt its strategy amid evolving economic conditions.
